MedPath

Transversus Abdominis Plane Block and Inguinal Hernia Repair

Not Applicable
Completed
Conditions
Regional Anesthesia
Postoperative Pain
Abdominal Wall Muscles
Inguinal Hernia
Registration Number
NCT02030223
Lead Sponsor
Papacharalampous Panagiota
Brief Summary

This prospective, randomized, double blinded, placebo-controlled study is designed to evaluate the postoperative analgesic efficacy of the ultrasound-guided transversus abdominis plane block with ropivacaine 0,75 %, in patients undergoing unilateral inguinal hernia repair with a mesh under general anaesthesia, and how the efficiency of early postoperative analgesia achieved correlates with the risk of developing a chronic pain state, a not uncommon condition after this type of surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria

ASA I-III patients undergoing inguinal hernia repair with a mesh

age between 18 and 75 years old

ability to read and write greek

Exclusion Criteria
  • Inability to consent to the study
  • BMI >40kg/m2
  • Skin infection at the puncture site
  • Contraindication to mono-amide local anaesthetics, paracetamol, NSAID's (parecoxib)
  • Preoperative use of opioids or NSAID's for chronic pain conditions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain scores at rest and with movement using the numerical rating scale (NRS)3, 6 and 24 hours postoperatively
Secondary Outcome Measures
NameTimeMethod
Incidence of chronic pain6 months after surgery

Trial Locations

Locations (1)

Aretaieion University Hospital

🇬🇷

Athens, Greece

Aretaieion University Hospital
🇬🇷Athens, Greece

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.